These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24732594)

  • 1. Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.
    Veronese A; Pepe F; Chiacchia J; Pagotto S; Lanuti P; Veschi S; Di Marco M; D'Argenio A; Innocenti I; Vannata B; Autore F; Marchisio M; Wernicke D; Verginelli F; Leone G; Rassenti LZ; Kipps TJ; Mariani-Costantini R; Laurenti L; Croce CM; Visone R
    Leukemia; 2015 Jan; 29(1):86-95. PubMed ID: 24732594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.
    Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E
    Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.
    Fabbri M; Bottoni A; Shimizu M; Spizzo R; Nicoloso MS; Rossi S; Barbarotto E; Cimmino A; Adair B; Wojcik SE; Valeri N; Calore F; Sampath D; Fanini F; Vannini I; Musuraca G; Dell'Aquila M; Alder H; Davuluri RV; Rassenti LZ; Negrini M; Nakamura T; Amadori D; Kay NE; Rai KR; Keating MJ; Kipps TJ; Calin GA; Croce CM
    JAMA; 2011 Jan; 305(1):59-67. PubMed ID: 21205967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.
    Klein U; Lia M; Crespo M; Siegel R; Shen Q; Mo T; Ambesi-Impiombato A; Califano A; Migliazza A; Bhagat G; Dalla-Favera R
    Cancer Cell; 2010 Jan; 17(1):28-40. PubMed ID: 20060366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
    Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
    Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1.
    Lerner M; Harada M; Lovén J; Castro J; Davis Z; Oscier D; Henriksson M; Sangfelt O; Grandér D; Corcoran MM
    Exp Cell Res; 2009 Oct; 315(17):2941-52. PubMed ID: 19591824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leukemia.
    Humplikova L; Kollinerova S; Papajik T; Pikalova Z; Holzerova M; Prochazka V; Divoka M; Modriansky M; Indrak K; Jarosova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):284-93. PubMed ID: 24026141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large fraction of trisomy 12, 17p
    Pepe F; Rassenti LZ; Pekarsky Y; Labanowska J; Nakamura T; Nigita G; Kipps TJ; Balatti V; Croce CM
    Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35064090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL).
    Kasar S; Underbayev C; Hassan M; Ilev I; Degheidy H; Bauer S; Marti G; Lutz C; Raveche E; Batish M
    PLoS One; 2016; 11(3):e0149331. PubMed ID: 26959643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL).
    Hanlon K; Rudin CE; Harries LW
    PLoS One; 2009 Sep; 4(9):e7169. PubMed ID: 19779621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity.
    Salerno E; Scaglione BJ; Coffman FD; Brown BD; Baccarini A; Fernandes H; Marti G; Raveche ES
    Mol Cancer Ther; 2009 Sep; 8(9):2684-92. PubMed ID: 19723889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia.
    Ouillette P; Collins R; Shakhan S; Li J; Li C; Shedden K; Malek SN
    Clin Cancer Res; 2011 Nov; 17(21):6778-90. PubMed ID: 21890456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of 13q14.3 deletion by cytogenetic analysis and FISH technique and miRNA-15a and miRNA-16-1 by real time PCR in chronic lymphocytic leukemia.
    Yılmaz M; Kuru RD; Erdoğan I; Soysal T; Hacıhanefioglu S; Baykara O
    Afr Health Sci; 2022 Sep; 22(3):173-182. PubMed ID: 36910369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia.
    Sampath D; Liu C; Vasan K; Sulda M; Puduvalli VK; Wierda WG; Keating MJ
    Blood; 2012 Feb; 119(5):1162-72. PubMed ID: 22096249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection.
    Smonskey MT; Block AW; Deeb G; Chanan-Khan AA; Bernstein ZP; Miller KC; Wallace PK; Starostik P
    Am J Clin Pathol; 2012 Apr; 137(4):641-6. PubMed ID: 22431542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lymphocytic leukemia and 13q14: miRs and more.
    Mertens D; Philippen A; Ruppel M; Allegra D; Bhattacharya N; Tschuch C; Wolf S; Idler I; Zenz T; Stilgenbauer S
    Leuk Lymphoma; 2009 Mar; 50(3):502-5. PubMed ID: 19347735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
    Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
    Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.
    Li F; Xu Y; Deng S; Li Z; Zou D; Yi S; Sui W; Hao M; Qiu L
    Oncotarget; 2015 Nov; 6(35):38270-82. PubMed ID: 26516702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.
    Cutrona G; Matis S; Colombo M; Massucco C; Baio G; Valdora F; Emionite L; Fabris S; Recchia AG; Gentile M; Neumaier CE; Reverberi D; Massara R; Boccardo S; Basso L; Salvi S; Rosa F; Cilli M; Zupo S; Truini M; Tassone P; Calabrese M; Negrini M; Neri A; Morabito F; Fais F; Ferrarini M
    Leukemia; 2017 Sep; 31(9):1894-1904. PubMed ID: 28053325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
    Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP
    Cancer; 2008 Mar; 112(6):1296-305. PubMed ID: 18246537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.